Literature DB >> 1622651

Psychometric validation of the EORTC Core Quality of Life Questionnaire, 30-item version and a diagnosis-specific module for head and neck cancer patients.

K Bjordal1, S Kaasa.   

Abstract

A cancer-specific self-reporting quality of life questionnaire has been validated. The questionnaire is designed to assess physical functioning, role functioning, cognitive functioning, emotional functioning, social functioning, pain, fatigue, emesis and quality of life by means of multi-item scales, and other disease- and treatment-related symptoms by means of single items. The questionnaire was completed by 126 head and neck cancer patients with a mean age of 67 years. The internal consistency (scale reliability) was satisfactory for all scales but one. Correlations between scales and items assessing the same underlying dimension were also satisfactory. The questionnaire discriminates between patient subgroups and between acute, subacute and late toxicity. Patient compliance was high. The questionnaire provided valuable information, and most of the scales/items functioned well. A few problems were found, especially with the modified visual analogue scales, and minor modifications will be made.

Entities:  

Mesh:

Year:  1992        PMID: 1622651     DOI: 10.3109/02841869209108178

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  75 in total

1.  Distinguishing between quality of life and health status in quality of life research: a meta-analysis.

Authors:  K W Smith; N E Avis; S F Assmann
Journal:  Qual Life Res       Date:  1999-08       Impact factor: 4.147

2.  A follow-up study of the quality of life in cancer patients with different prognoses.

Authors:  G I Ringdal; K Ringdal
Journal:  Qual Life Res       Date:  2000-02       Impact factor: 4.147

3.  Prognostic value of quality of life measured after treatment on subsequent survival in patients with nasopharyngeal carcinoma.

Authors:  Wen-Ling Tsai; Chih-Yen Chien; Hsuan-Ying Huang; Kuan-Cho Liao; Fu-Min Fang
Journal:  Qual Life Res       Date:  2012-06-06       Impact factor: 4.147

Review 4.  A review of the progress towards developing health-related quality-of-life instruments for international clinical studies and outcomes research.

Authors:  R T Anderson; N K Aaronson; M Bullinger; W L McBee
Journal:  Pharmacoeconomics       Date:  1996-10       Impact factor: 4.981

5.  Stigma, perceived blame, self-blame, and depressive symptoms in men with colorectal cancer.

Authors:  Sean M Phelan; Joan M Griffin; George L Jackson; S Yousuf Zafar; Wendy Hellerstedt; Mandy Stahre; David Nelson; Leah L Zullig; Diana J Burgess; Michelle van Ryn
Journal:  Psychooncology       Date:  2011-09-26       Impact factor: 3.894

6.  Effect of neurological dysfunction on health-related quality of life in patients with high-grade glioma.

Authors:  D Osoba; N K Aaronson; M Muller; K Sneeuw; M A Hsu; W K Yung; M Brada; E Newlands
Journal:  J Neurooncol       Date:  1997-09       Impact factor: 4.130

7.  Minimally invasive esophagectomy: short- and long-term outcomes.

Authors:  S Leibman; B M Smithers; D C Gotley; I Martin; J Thomas
Journal:  Surg Endosc       Date:  2005-12-28       Impact factor: 4.584

8.  Anxiety, depression and quality of life in colorectal cancer patients.

Authors:  Akira Tsunoda; Kentaro Nakao; Kenshi Hiratsuka; Naokuni Yasuda; Miki Shibusawa; Mitsuo Kusano
Journal:  Int J Clin Oncol       Date:  2005-12       Impact factor: 3.402

Review 9.  Psychosocial Issues in Patients with Head and Neck Cancer: an Updated Review with a Focus on Clinical Interventions.

Authors:  Joshua D Smith; Andrew G Shuman; Michelle B Riba
Journal:  Curr Psychiatry Rep       Date:  2017-09       Impact factor: 5.285

10.  Radiation related morbidities and their impact on quality of life in head and neck cancer patients receiving radical radiotherapy.

Authors:  M Bansal; B K Mohanti; N Shah; R Chaudhry; S Bahadur; N K Shukla
Journal:  Qual Life Res       Date:  2004-03       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.